Biz in Saigon

Key Economic Developments in Vietnam 2025: Robust FDI Realization, Record Trade Turnover, and Major Infrastructure Advances

1/ Vietnam FDI Surpasses 38 billion USD in 2025; Realized Capital Hits Five-Year High According to the General Statistics Office (GSO) under the Ministry of Finance, total registered Foreign Direct Investment (FDI) into Vietnam reached 38.42 billion USD [...]

Read more

Latest News

Allantoin Market Set to Soar: From USD 461.7 Million in 2025 to USD 805.6 Million by 2035 with a CAGR of 5.7%

Global Allantoin Market Set for Growth with Multifunctional Skin-Conditioning Trends & Clean Beauty Movement Dublin, [...]

US, EU and Canada Dietary Supplements Regulatory Compliance Training Course: Strengthening FDA Readiness, GMP Standards, and Formulation Quality (Jan 15th – Jan 16th, 2026 on ON-DEMAND)

The market opportunity lies in providing comprehensive training on GMP compliance for dietary supplements, highlighting [...]

Verano Announces Agreement to Upsize Revolving Credit Facility Commitment to $100,000,000 and Extend Maturity Date

Amendment adds incremental $25,000,000 and extends maturity date from September 29, 2028 to February 28, [...]

AAVantgarde Completes Enrollment in LUCE-1 Phase 1/2 Clinical Trial of AAVB-081 for Usher Syndrome Type B-associated Retinitis Pigmentosa

This milestone marks significant progress in the first-in-human evaluation of AAVantgarde’s dual-AAV gene therapy designed [...]

Axsome Therapeutics Initiates FORWARD Phase 3 Trial of AXS-14 for the Management of Fibromyalgia

NEW YORK, Jan. 15, 2026 (GLOBE NEWSWIRE) — Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical [...]

Abpro’s Lead Program ABP-102 Featured in Celltrion Presentation at the 44th Annual J.P. Morgan Healthcare Conference

Recently IND-Cleared HER2 × CD3 T-Cell Engager Highlighted by Global Biopharmaceutical Partner BURLINGTON, Mass., Jan. [...]

Most Read

Don’t miss it

Allantoin Market Set to Soar: From USD 461.7 Million in 2025 to USD 805.6 Million by 2035 with a CAGR of 5.7%

Global Allantoin Market Set for Growth with Multifunctional Skin-Conditioning Trends & Clean Beauty Movement Dublin, [...]

US, EU and Canada Dietary Supplements Regulatory Compliance Training Course: Strengthening FDA Readiness, GMP Standards, and Formulation Quality (Jan 15th – Jan 16th, 2026 on ON-DEMAND)

The market opportunity lies in providing comprehensive training on GMP compliance for dietary supplements, highlighting [...]

Verano Announces Agreement to Upsize Revolving Credit Facility Commitment to $100,000,000 and Extend Maturity Date

Amendment adds incremental $25,000,000 and extends maturity date from September 29, 2028 to February 28, [...]

AAVantgarde Completes Enrollment in LUCE-1 Phase 1/2 Clinical Trial of AAVB-081 for Usher Syndrome Type B-associated Retinitis Pigmentosa

This milestone marks significant progress in the first-in-human evaluation of AAVantgarde’s dual-AAV gene therapy designed [...]

Axsome Therapeutics Initiates FORWARD Phase 3 Trial of AXS-14 for the Management of Fibromyalgia

NEW YORK, Jan. 15, 2026 (GLOBE NEWSWIRE) — Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical [...]

Abpro’s Lead Program ABP-102 Featured in Celltrion Presentation at the 44th Annual J.P. Morgan Healthcare Conference

Recently IND-Cleared HER2 × CD3 T-Cell Engager Highlighted by Global Biopharmaceutical Partner BURLINGTON, Mass., Jan. [...]